Calamos Advisors LLC elevated its stake in Elevance Well being, Inc. (NYSE:ELV – Free Report) by 0.8% within the 2nd quarter, in keeping with the corporate in its most up-to-date 13F submitting with the Securities and Trade Fee. The fund owned 24,344 shares of the corporate’s inventory after shopping for a further 184 shares through the quarter. Calamos Advisors LLC’s holdings in Elevance Well being had been value $13,191,000 as of its most up-to-date SEC submitting.
A number of different hedge funds and different institutional traders have additionally made modifications to their positions within the firm. Canoe Monetary LP grew its place in shares of Elevance Well being by 158.1% within the 4th quarter. Canoe Monetary LP now owns 844,122 shares of the corporate’s inventory valued at $398,054,000 after buying a further 517,116 shares through the interval. Tower Analysis Capital LLC TRC raised its stake in Elevance Well being by 114.8% within the fourth quarter. Tower Analysis Capital LLC TRC now owns 31,311 shares of the corporate’s inventory valued at $14,765,000 after shopping for a further 16,737 shares through the interval. Commonwealth Fairness Companies LLC lifted its place in shares of Elevance Well being by 8.6% within the fourth quarter. Commonwealth Fairness Companies LLC now owns 55,262 shares of the corporate’s inventory valued at $26,060,000 after shopping for a further 4,362 shares over the last quarter. Courageous Warrior Advisors LLC boosted its stake in shares of Elevance Well being by 7.9% through the 4th quarter. Courageous Warrior Advisors LLC now owns 1,756,653 shares of the corporate’s inventory value $828,367,000 after buying a further 129,055 shares through the interval. Lastly, New Mexico Instructional Retirement Board boosted its stake in shares of Elevance Well being by 14.6% through the 1st quarter. New Mexico Instructional Retirement Board now owns 14,146 shares of the corporate’s inventory value $6,949,000 after buying a further 1,800 shares through the interval. 89.24% of the inventory is owned by institutional traders.
Wall Road Analysts Forecast Progress
ELV has been the topic of a number of analysis experiences. TD Cowen lower their value goal on Elevance Well being from $624.00 to $589.00 and set a “purchase” score for the corporate in a report on Friday, July nineteenth. Robert W. Baird began protection on shares of Elevance Well being in a analysis be aware on Thursday, Might thirtieth. They issued an “outperform” score and a $649.00 value goal on the inventory. Financial institution of America restated a “impartial” score and set a $530.00 value goal (down beforehand from $646.00) on shares of Elevance Well being in a report on Thursday, July 18th. Stephens reiterated an “chubby” score and issued a $615.00 value goal on shares of Elevance Well being in a analysis be aware on Tuesday, June eleventh. Lastly, StockNews.com lower Elevance Well being from a “strong-buy” score to a “purchase” score in a analysis be aware on Thursday, June sixth. One analyst has rated the inventory with a maintain score, fourteen have given a purchase score and one has issued a robust purchase score to the corporate. In keeping with MarketBeat.com, the corporate at the moment has a median score of “Purchase” and a median value goal of $604.29.
Examine Out Our Newest Analysis Report on ELV
Insider Transactions at Elevance Well being
In associated information, Director Robert L. Dixon, Jr. bought 305 shares of the agency’s inventory in a transaction on Friday, July nineteenth. The inventory was bought at a median value of $506.76, for a complete transaction of $154,561.80. Following the sale, the director now owns 9,721 shares of the corporate’s inventory, valued at roughly $4,926,213.96. The transaction was disclosed in a doc filed with the SEC, which is offered at this hyperlink. In associated information, Director Robert L. Dixon, Jr. bought 305 shares of the agency’s inventory in a transaction that occurred on Friday, July nineteenth. The shares had been bought at a median value of $506.76, for a complete worth of $154,561.80. Following the completion of the transaction, the director now owns 9,721 shares within the firm, valued at roughly $4,926,213.96. The sale was disclosed in a doc filed with the SEC, which could be accessed via this hyperlink. Additionally, CEO Gail Boudreaux bought 34,000 shares of Elevance Well being inventory in a transaction that occurred on Monday, July twenty second. The inventory was bought at a median value of $500.98, for a complete transaction of $17,033,320.00. Following the sale, the chief government officer now owns 126,709 shares within the firm, valued at $63,478,674.82. The disclosure for this sale could be discovered right here. Over the past ninety days, insiders bought 35,058 shares of firm inventory value $17,588,116. Company insiders personal 0.35% of the corporate’s inventory.
Elevance Well being Buying and selling Up 0.5 %
Shares of ELV opened at $545.96 on Monday. The corporate has a debt-to-equity ratio of 0.58, a fast ratio of 1.49 and a present ratio of 1.49. Elevance Well being, Inc. has a 52-week low of $431.38 and a 52-week excessive of $555.35. The agency has a market cap of $126.89 billion, a price-to-earnings ratio of 20.63, a PEG ratio of 1.18 and a beta of 0.84. The enterprise’s fifty day transferring common is $530.61 and its 200-day transferring common is $523.70.
Elevance Well being (NYSE:ELV – Get Free Report) final launched its earnings outcomes on Wednesday, July seventeenth. The corporate reported $10.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.99 by $0.13. The agency had income of $43.22 billion for the quarter, in comparison with analysts’ expectations of $42.99 billion. Elevance Well being had a return on fairness of 20.64% and a internet margin of three.89%. The enterprise’s income for the quarter was down .4% on a year-over-year foundation. Throughout the identical quarter within the earlier 12 months, the enterprise posted $9.04 earnings per share. Equities analysts anticipate that Elevance Well being, Inc. will put up 37.25 EPS for the present fiscal 12 months.
Elevance Well being Dividend Announcement
The enterprise additionally just lately introduced a quarterly dividend, which will likely be paid on Wednesday, September twenty fifth. Shareholders of file on Tuesday, September tenth will likely be paid a dividend of $1.63 per share. The ex-dividend date of this dividend is Tuesday, September tenth. This represents a $6.52 dividend on an annualized foundation and a dividend yield of 1.19%. Elevance Well being’s payout ratio is presently 24.64%.
Elevance Well being Firm Profile
Elevance Well being, Inc, along with its subsidiaries, operates as a well being advantages firm in america. The corporate operates via 4 segments: Well being Advantages, CarelonRx, Carelon Companies, and Company & Different. It presents a wide range of well being plans and companies to program members; well being merchandise; an array of fee-based administrative managed care companies; and specialty and different insurance coverage services, akin to cease loss, dental, imaginative and prescient, life, incapacity, and supplemental medical insurance advantages.
Really useful Tales
Wish to see what different hedge funds are holding ELV? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Elevance Well being, Inc. (NYSE:ELV – Free Report).
Obtain Information & Scores for Elevance Well being Day by day – Enter your electronic mail deal with beneath to obtain a concise day by day abstract of the most recent information and analysts’ scores for Elevance Well being and associated firms with MarketBeat.com’s FREE day by day electronic mail publication.
